These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 11073267)
21. Pathogenesis and medical treatment of secondary hyperparathyroidism. Fukagawa M; Kurokawa K Semin Surg Oncol; 1997; 13(2):73-7. PubMed ID: 9088062 [TBL] [Abstract][Full Text] [Related]
29. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Slatopolsky E; Brown A; Dusso A Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S54-7. PubMed ID: 11158862 [TBL] [Abstract][Full Text] [Related]
30. Transcription factor MafB may play an important role in secondary hyperparathyroidism. Morito N; Yoh K; Usui T; Oishi H; Ojima M; Fujita A; Koshida R; Shawki HH; Hamada M; Muratani M; Yamagata K; Takahashi S Kidney Int; 2018 Jan; 93(1):54-68. PubMed ID: 28964572 [TBL] [Abstract][Full Text] [Related]
31. Has parathyroid hormone any influence on lipid metabolism in chronic renal failure? Arnadottir M; Nilsson-Ehle P Nephrol Dial Transplant; 1995 Dec; 10(12):2381-2. PubMed ID: 8808260 [No Abstract] [Full Text] [Related]
32. Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia. Matsushita H; Hara M; Endo Y; Shishiba Y; Hara S; Ubara Y; Nakazawa H; Suzuki N; Kawaminami K; Kido T; Li Q; Grimelius L Kidney Int; 1999 Jan; 55(1):130-8. PubMed ID: 9893121 [TBL] [Abstract][Full Text] [Related]
33. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve. Bas S; Aguilera-Tejero E; Bas A; Estepa JC; Lopez I; Madueño JA; Rodriguez M J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800 [TBL] [Abstract][Full Text] [Related]
34. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Goodman WG; Quarles LD Kidney Int; 2008 Aug; 74(3):276-88. PubMed ID: 17568787 [TBL] [Abstract][Full Text] [Related]
35. [New insights in the pathogenesis of secondary hyperparathyroidism]. Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Bellasi A; Galassi A; Gallieni M; Brancaccio D G Ital Nefrol; 2005; 22(4):329-36. PubMed ID: 16267793 [TBL] [Abstract][Full Text] [Related]
36. Parathyroid dysfunction end stage renal disease. DiTella PJ; Lang GR Otolaryngol Clin North Am; 1980 Feb; 13(1):193-201. PubMed ID: 7367004 [No Abstract] [Full Text] [Related]
37. [Parathyroid hormone and calcitonin in chronic kidney failure]. Okazaki R; Matsumoto T Nihon Rinsho; 1992 Jan; 50 Suppl():600-5. PubMed ID: 1578744 [No Abstract] [Full Text] [Related]
38. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus. Yi H; Fukagawa M; Yamato H; Kumagai M; Watanabe T; Kurokawa K Nephron; 1995; 70(2):242-8. PubMed ID: 7566311 [TBL] [Abstract][Full Text] [Related]
39. Hyperparathyroidism and parathyroidectomy in renal failure. Kaye M Int J Artif Organs; 1990 Dec; 13(12):787-9. PubMed ID: 2289829 [No Abstract] [Full Text] [Related]
40. Parathyroid growth and suppression in renal failure. Lewin E; Huan J; Olgaard K Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]